Wells Fargo
ELV icon

Wells Fargo’s Elevance Health ELV Stock Holding History

Wells Fargo’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,700
Closed -$946K – 7268
2025
Q4 		$946K Sell
2,700
-24,700
-90% -$8.35M ﹤0.01% 4014
2025
Q3 		$8.85M Buy
27,400
+26,700
+3,814% +$8.3M ﹤0.01% 2099
2025
Q2 		$272K Buy
+700
New +$282K ﹤0.01% 4578
2017
Q3 		– Sell
-16,800
Closed -$26K – 6338
2017
Q2 		$26K Sell
16,800
-24,000
-59% -$4.31M ﹤0.01% 5565
2017
Q1 		$159K Buy
+40,800
New +$6.49M ﹤0.01% 4951
2015
Q3 		– Sell
-30,000
Closed -$10K – 6251
2015
Q2 		$10K Buy
+30,000
New +$4.79M ﹤0.01% 5805

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Wells Fargo's ELV Position: Q1 2026 in Review

Wells Fargo increased its Elevance Health (ELV) stake by 0.57% in Q1 2026, buying an estimated $673K and bringing the position to 361,193 shares worth $106M. The position accounts for 0.02% of the portfolio, ranked #604.

Wells Fargo first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $270M in Q2 2019. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Wells Fargo held 361,193 shares of Elevance Health worth $106M as of Q1 2026.
  • Wells Fargo bought 2,048 Elevance Health shares in Q1 2026, an estimated $673K.
  • Elevance Health made up 0.02% of Wells Fargo's portfolio in Q1 2026, its #604 holding.
  • Wells Fargo first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
  • Wells Fargo's Elevance Health position peaked at $270M in Q2 2019.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.